Last 48 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 38.85 | 35.47 | 19.96 | 33.38 | — | 63.44 | 61.25 | — | 32.74 | 57.37 | 83.45 | — | — | 93.83 | 242.65 | — | — | 58.80 | 142.19 | 190.43 | 161.11 |
| — | -44.1% | -67.4% | — | — | +10.6% | -26.6% | — | — | -38.9% | -65.6% | — | — | +59.6% | +70.7% | — | — | -3.3% | +61.5% | +76.0% | +98.7% | |
| P/S Ratio | 1.37 | 1.28 | 1.53 | 1.24 | 1.62 | 1.12 | 1.19 | 1.51 | 1.68 | 1.79 | 1.13 | 1.36 | 1.65 | 1.72 | 2.80 | 2.27 | 1.89 | 2.86 | 3.97 | 4.87 | 7.23 |
| — | +14.2% | +29.0% | -18.1% | -3.3% | -37.2% | +5.6% | +11.2% | +1.5% | +4.2% | -59.8% | -40.1% | -12.6% | -40.0% | -29.4% | -53.4% | -73.8% | -52.7% | -39.3% | -18.6% | +36.5% | |
| P/B Ratio | 1.41 | 1.20 | 1.48 | 1.22 | 1.65 | 1.14 | 1.09 | 1.30 | 1.66 | 1.64 | 1.04 | 1.12 | 1.44 | 1.73 | 2.88 | 2.30 | 1.99 | 3.51 | 4.82 | 5.77 | 7.84 |
| — | +4.9% | +35.6% | -5.8% | -0.2% | -30.4% | +5.5% | +15.2% | +15.0% | -4.9% | -64.0% | -51.2% | -27.8% | -50.8% | -40.2% | -60.1% | -74.6% | -45.6% | -28.9% | -3.1% | +43.7% | |
| P/FCF | 11.75 | 18.24 | 7.90 | 9.11 | 25.19 | 18.87 | 11.15 | 27.61 | 10.90 | 53.73 | 6.90 | 8.88 | 16.43 | 11.07 | 13.67 | 250.43 | 8.22 | 118.50 | — | — | 46.31 |
| — | -3.4% | -29.1% | -67.0% | +131.1% | -64.9% | +61.6% | +210.7% | -33.7% | +385.4% | -49.5% | -96.5% | +99.8% | -90.7% | — | — | -82.2% | +138.9% | — | — | +148.6% | |
| EV / EBITDA | 11.60 | 10.92 | 8.57 | 10.02 | 22.04 | 12.03 | 11.48 | 39.82 | 14.40 | 17.99 | 12.53 | 80.01 | 1293.94 | 20.35 | 28.02 | 577.48 | — | 25.11 | 37.21 | 55.51 | 66.35 |
| — | -9.2% | -25.4% | -74.8% | +53.0% | -33.1% | -8.4% | -50.2% | -98.9% | -11.6% | -55.3% | -86.1% | — | -19.0% | -24.7% | +940.4% | — | -29.8% | +3.9% | +48.2% | +100.5% | |
| EV / EBIT | 146.25 | 23.05 | 14.07 | 22.13 | 141.08 | 35.63 | 31.63 | — | 20.97 | 40.49 | 34.95 | — | — | 149.45 | 115.03 | — | — | 58.75 | 112.88 | 322.25 | 198.18 |
| — | -35.3% | -55.5% | — | +572.8% | -12.0% | -9.5% | — | — | -72.9% | -69.6% | — | — | +154.4% | +1.9% | — | — | -4.5% | +85.1% | +321.0% | +201.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.9% | 44.8% | 49.0% | 45.3% | 41.5% | 43.3% | 43.9% | 41.1% | 46.6% | 43.5% | 41.3% | 38.7% | 40.7% | 44.2% | 45.0% | 43.0% | 40.9% | 45.7% | 47.7% | 47.1% | 48.0% |
| — | +3.4% | +11.5% | +10.1% | -10.9% | -0.5% | +6.4% | +6.2% | +14.4% | -1.5% | -8.1% | -10.0% | -0.4% | -3.3% | -5.7% | -8.6% | -14.8% | -7.7% | -4.5% | -3.1% | -3.3% | |
| Operating Margin | 1.0% | 4.9% | 10.4% | 5.4% | 0.4% | 2.7% | 2.8% | -4.3% | 4.5% | 2.5% | 1.2% | -7.6% | -9.0% | 1.2% | 2.6% | -7.9% | -12.9% | 5.3% | 3.8% | 1.6% | 3.7% |
| — | +82.8% | +271.9% | +226.2% | -90.0% | +4.3% | +139.9% | +43.2% | +149.7% | +104.7% | -55.1% | +3.9% | +29.9% | -76.6% | -31.2% | -595.5% | -445.8% | -46.5% | -64.5% | -79.5% | -54.1% | |
| Net Margin | 0.2% | 3.6% | 7.8% | 3.7% | -0.6% | 1.8% | 1.9% | -2.6% | 5.2% | 3.1% | 1.3% | -6.4% | -5.6% | 1.9% | 1.2% | -5.2% | -9.5% | 4.8% | 2.7% | 2.6% | 4.5% |
| — | +104.0% | +300.9% | +240.7% | -112.5% | -42.5% | +43.8% | +59.1% | +193.0% | +64.3% | +16.9% | -23.4% | +41.8% | -61.4% | -57.8% | -300.4% | -312.3% | -51.3% | -63.5% | -54.1% | -31.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.2% | 0.8% | 1.9% | 0.9% | -0.2% | 0.4% | 0.4% | -0.6% | 1.3% | 0.7% | 0.3% | -1.3% | -1.2% | 0.5% | 0.3% | -1.3% | -2.5% | 1.5% | 0.8% | 0.7% | 1.2% |
| — | +92.6% | +326.1% | +262.5% | -112.9% | -38.0% | +43.2% | +57.4% | +205.8% | +50.1% | +4.4% | +0.1% | +51.8% | -68.6% | -64.2% | -278.5% | -302.5% | -44.4% | -57.7% | -48.2% | -28.7% | |
| ROA | 0.1% | 0.5% | 1.2% | 0.6% | -0.1% | 0.3% | 0.3% | -0.3% | 0.7% | 0.4% | 0.2% | -0.7% | -0.6% | 0.3% | 0.2% | -0.7% | -1.3% | 0.8% | 0.4% | 0.4% | 0.7% |
| — | +104.1% | +362.3% | +273.6% | -114.4% | -29.0% | +60.7% | +52.7% | +210.8% | +49.3% | +5.2% | -3.4% | +50.1% | -67.7% | -63.6% | -274.6% | -294.1% | -46.7% | -59.8% | -49.4% | -27.9% | |
| ROIC | 0.7% | 0.9% | 2.0% | 1.0% | 0.1% | 0.5% | 0.5% | -0.7% | 0.8% | 0.4% | 0.2% | -1.1% | -1.3% | 0.2% | 0.4% | -1.2% | -2.0% | 0.9% | 0.6% | 0.3% | 0.7% |
| — | +89.1% | +313.8% | +248.2% | -89.6% | +16.6% | +156.7% | +35.0% | +162.6% | +108.5% | -54.4% | +12.2% | +34.2% | -78.3% | -35.8% | -540.2% | -385.5% | -54.6% | -70.7% | -81.2% | -58.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.14 | 0.15 | 0.16 | 0.17 | 0.17 | 0.30 | 0.31 | 0.31 | 0.50 | 0.51 | 0.52 | 0.52 | 0.52 | 0.53 | 0.54 | 0.55 | 0.54 | 0.57 | 0.57 | 0.47 |
| — | -15.0% | -49.1% | -47.6% | -46.1% | -66.0% | -40.5% | -40.7% | -40.4% | -3.3% | -3.1% | -3.8% | -5.4% | -5.3% | -7.0% | -5.7% | +15.7% | +12.9% | +12.2% | +8.9% | -13.6% | |
| Debt / EBITDA | 2.08 | 5.69 | 3.76 | 5.41 | 8.81 | 6.98 | 12.91 | 37.74 | 10.63 | 21.37 | 23.64 | 136.82 | 1710.56 | 22.46 | 19.32 | 488.54 | — | 14.31 | 16.38 | 20.78 | 15.63 |
| — | -18.5% | -70.9% | -85.7% | -17.1% | -67.3% | -45.4% | -72.4% | -99.4% | -4.8% | +22.3% | -72.0% | — | +56.9% | +18.0% | +2250.9% | — | +34.9% | +51.4% | +57.1% | +19.0% | |
| Current Ratio | 1.43 | 1.66 | 1.64 | 1.50 | 1.43 | 1.44 | 1.42 | 1.38 | 1.37 | 1.05 | 2.45 | 2.38 | 2.52 | 2.47 | 2.38 | 2.06 | 2.06 | 2.25 | 2.11 | 0.82 | 0.89 |
| — | +14.6% | +15.6% | +8.2% | +4.2% | +37.4% | -41.9% | -41.9% | -45.7% | -57.5% | +2.7% | +15.4% | +22.5% | +9.7% | +12.9% | +152.5% | +131.0% | -14.1% | -32.1% | -73.6% | -70.3% | |
| Quick Ratio | 1.22 | 1.45 | 1.43 | 1.29 | 1.22 | 1.21 | 1.24 | 1.23 | 1.22 | 0.95 | 2.22 | 2.13 | 2.22 | 2.16 | 2.03 | 1.75 | 1.71 | 1.86 | 1.71 | 0.67 | 0.75 |
| — | +19.7% | +14.8% | +4.7% | -0.4% | +26.9% | -43.9% | -42.1% | -45.1% | -55.9% | +9.3% | +21.8% | +29.7% | +15.9% | +18.9% | +160.4% | +127.2% | -19.5% | -38.7% | -75.7% | -71.6% | |
| Interest Coverage | 3.90 | — | — | 23.03 | 1.24 | 34.46 | 30.95 | -26.46 | 22.22 | 11.21 | 8.21 | -14.70 | — | — | — | — | — | 16.38 | — | 44.60 | 2.04 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OMCL stock.
Omnicell, Inc.'s current P/E is 38.8x. The average P/E over the last 3 quarters is 29.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Omnicell, Inc.'s current operating margin is 1.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Omnicell, Inc.'s business trajectory between earnings reports.